CA3200150A1 - Antibody against novel coronavirus, and kit for novel coronavirus detection - Google Patents

Antibody against novel coronavirus, and kit for novel coronavirus detection

Info

Publication number
CA3200150A1
CA3200150A1 CA3200150A CA3200150A CA3200150A1 CA 3200150 A1 CA3200150 A1 CA 3200150A1 CA 3200150 A CA3200150 A CA 3200150A CA 3200150 A CA3200150 A CA 3200150A CA 3200150 A1 CA3200150 A1 CA 3200150A1
Authority
CA
Canada
Prior art keywords
cdr
mutation
mutation combination
antibody
functional fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3200150A
Other languages
English (en)
French (fr)
Inventor
Peng Cui
Zhiqiang He
Yuan MENG
Dongmei ZHONG
Wenjuan LOU
Lingyun FAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fapon Biotech Inc
Original Assignee
Fapon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fapon Biotech Inc filed Critical Fapon Biotech Inc
Publication of CA3200150A1 publication Critical patent/CA3200150A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1002Coronaviridae
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/51Complete heavy chain or Fd fragment, i.e. VH + CH1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/515Complete light chain, i.e. VL + CL
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/165Coronaviridae, e.g. avian infectious bronchitis virus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA3200150A 2020-10-29 2021-09-10 Antibody against novel coronavirus, and kit for novel coronavirus detection Pending CA3200150A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202011179251.2A CN112239500B (zh) 2020-10-29 2020-10-29 抗新型冠状病毒的抗体和检测新型冠状病毒的试剂盒
CN202011179251.2 2020-10-29
PCT/CN2021/117805 WO2022089045A1 (zh) 2020-10-29 2021-09-10 抗新型冠状病毒的抗体和检测新型冠状病毒的试剂盒

Publications (1)

Publication Number Publication Date
CA3200150A1 true CA3200150A1 (en) 2022-05-05

Family

ID=74170193

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3200150A Pending CA3200150A1 (en) 2020-10-29 2021-09-10 Antibody against novel coronavirus, and kit for novel coronavirus detection

Country Status (5)

Country Link
JP (1) JP2023551102A (zh)
KR (1) KR20230093028A (zh)
CN (2) CN112239500B (zh)
CA (1) CA3200150A1 (zh)
WO (1) WO2022089045A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112239501B (zh) * 2020-10-29 2022-01-07 东莞市朋志生物科技有限公司 抗新型冠状病毒的抗体、检测新型冠状病毒试剂和试剂盒
CN112239500B (zh) * 2020-10-29 2022-01-07 东莞市朋志生物科技有限公司 抗新型冠状病毒的抗体和检测新型冠状病毒的试剂盒
CA3224182A1 (en) 2021-06-17 2022-12-22 Fapon Biotech Inc. Chimeric immunoglobulin
CN114409767A (zh) * 2021-12-08 2022-04-29 广东菲鹏生物有限公司 一种鉴别新冠突变型抗原的抗体、试剂及方法
CN116444656B (zh) * 2022-01-10 2023-09-22 东莞市朋志生物科技有限公司 一种鉴别新冠突变型抗原的抗体、试剂及方法
CN116444657B (zh) * 2022-01-10 2023-10-31 东莞市朋志生物科技有限公司 抗新型冠状病毒的抗体、检测新型冠状病毒试剂和试剂盒
CN117402239B (zh) * 2022-07-07 2024-05-10 东莞市朋志生物科技有限公司 一种抗糖化血红蛋白抗体、检测糖化血红蛋白的试剂和试剂盒
CN117487010A (zh) * 2022-08-02 2024-02-02 东莞市朋志生物科技有限公司 抗四碘甲状腺素抗体或其功能性片段、检测四碘甲状腺素的试剂和试剂盒
CN117659180A (zh) * 2022-09-06 2024-03-08 东莞市朋志生物科技有限公司 抗新型冠状病毒抗体或其功能性片段、检测新型冠状病毒的试剂和试剂盒
CN117886929A (zh) * 2022-10-08 2024-04-16 东莞市朋志生物科技有限公司 抗新型冠状病毒的抗体、检测新型冠状病毒的试剂和试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111239392B (zh) * 2020-02-26 2023-04-21 浙江诺迦生物科技有限公司 一种新型冠状病毒肺炎(covid-19)血清学诊断试剂盒
CN111273003A (zh) * 2020-03-05 2020-06-12 广州万孚生物技术股份有限公司 2019-nCoV新型冠状病毒快速检测免疫层析试纸条
CN111592594B (zh) * 2020-03-13 2022-05-10 北京大学 一种抗新型冠状病毒的单克隆抗体及其应用
CN111366735B (zh) * 2020-03-20 2021-07-13 广州市康润生物科技有限公司 新型冠状病毒更早期筛查方法
CN111257555A (zh) * 2020-04-03 2020-06-09 安徽省疾病预防控制中心(省健康教育所) 新冠病毒核酸重组酶介导等温扩增侧向层析胶体金快速检测方法及试纸条
CN111551743B (zh) * 2020-05-08 2021-02-05 北京贝尔生物工程股份有限公司 一种快速准确检测新型冠状病毒IgM抗体的试剂盒及其制备方法
CN111620946B (zh) * 2020-05-09 2020-12-22 江苏省疾病预防控制中心(江苏省公共卫生研究院) 分离的新型冠状病毒单克隆抗体或其抗原结合部分
CN111560070B (zh) * 2020-05-27 2021-10-01 江苏省疾病预防控制中心(江苏省公共卫生研究院) 针对新型冠状病毒np蛋白的抗体及其检测应用
CN111518202B (zh) * 2020-05-27 2021-10-19 江苏省疾病预防控制中心(江苏省公共卫生研究院) 新型冠状病毒抗体和新型冠状病毒抗体的elisa检测试剂盒
CN111748033B (zh) * 2020-05-27 2021-02-02 江苏省疾病预防控制中心(江苏省公共卫生研究院) 一种与新型冠状病毒np蛋白结合的分离抗体、包含其的检测试剂盒
CN111518203B (zh) * 2020-05-27 2021-10-19 江苏省疾病预防控制中心(江苏省公共卫生研究院) 用于新型冠状病毒检测的试剂盒
CN113278068B (zh) * 2020-06-04 2023-11-10 山东宽和正生物医药有限公司 针对新冠病毒SARS-CoV-2的单克隆抗体F5
CN111690060A (zh) * 2020-07-06 2020-09-22 深圳市亚辉龙生物科技股份有限公司 能够特异性识别RBD蛋白的IgA抗体以及试剂盒
CN112239500B (zh) * 2020-10-29 2022-01-07 东莞市朋志生物科技有限公司 抗新型冠状病毒的抗体和检测新型冠状病毒的试剂盒

Also Published As

Publication number Publication date
CN112239500A (zh) 2021-01-19
CN112239500B (zh) 2022-01-07
CN114426575B (zh) 2023-10-03
KR20230093028A (ko) 2023-06-26
JP2023551102A (ja) 2023-12-07
CN114426575A (zh) 2022-05-03
WO2022089045A1 (zh) 2022-05-05

Similar Documents

Publication Publication Date Title
CA3200150A1 (en) Antibody against novel coronavirus, and kit for novel coronavirus detection
CA3200148A1 (en) Antibody against novel coronavirus, and reagent and kit for detecting novel coronavirus
WO2020043068A1 (zh) 一种ns1蛋白的结合蛋白以及应用
CN112979788B (zh) 特异性结合HBeAg的结合蛋白、诊断HBV感染的试剂和试剂盒
WO2020043067A1 (zh) Ns1蛋白的结合蛋白
WO2023078447A1 (zh) 抗新型冠状病毒的抗体、检测新型冠状病毒试剂和试剂盒
WO2020043069A1 (zh) Ns1蛋白的结合蛋白
CA3111159A1 (en) Ns1-binding protein
WO2023131318A1 (zh) 抗新型冠状病毒的抗体、检测新型冠状病毒试剂和试剂盒
KR20210055754A (ko) 항 인간 심근 트로포닌 i의 항체 및 그 사용
CN112979787B (zh) 结合HBeAg的结合蛋白及其应用
KR102671155B1 (ko) Ns1 단백질의 결합 단백질
CN116496401B (zh) 抗异常凝血酶原的抗体、检测异常凝血酶原的试剂和试剂盒
WO2023241416A1 (zh) 抗p24抗体、检测p24的试剂和试剂盒
CN116444656B (zh) 一种鉴别新冠突变型抗原的抗体、试剂及方法
CN117659171A (zh) 抗HBeAg抗体或其功能性片段、检测HBeAg的试剂和试剂盒
CN117659180A (zh) 抗新型冠状病毒抗体或其功能性片段、检测新型冠状病毒的试剂和试剂盒
KR20240096684A (ko) Ns1 단백질의 결합 단백질 및 응용
CN117487003A (zh) 抗乙型流感病毒抗体或其功能性片段、检测乙型流感病毒的试剂和试剂盒
WO2020073833A1 (zh) 一种抗人心肌肌钙蛋白i的抗体及其应用
CN117720644A (zh) 抗猴痘病毒抗体或其抗原结合片段、检测猴痘病毒的试剂和试剂盒
CN118255889A (zh) 抗ca153抗体和检测试剂盒
CN117720642A (zh) 抗猴痘病毒抗体或其功能性片段、检测猴痘病毒的试剂和试剂盒
CN117886929A (zh) 抗新型冠状病毒的抗体、检测新型冠状病毒的试剂和试剂盒
CN117720643A (zh) 抗猴痘病毒抗体或其抗原结合片段、检测猴痘病毒的试剂和试剂盒

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230428

EEER Examination request

Effective date: 20230428

EEER Examination request

Effective date: 20230428

EEER Examination request

Effective date: 20230428

EEER Examination request

Effective date: 20230428